PortfoliosLab logoPortfoliosLab logo
Scilex Holding Company (SCLX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Mar 5, 2021

Highlights

Market Cap
$77.28M
Enterprise Value
$198.58M
EPS (TTM)
-$32.40
Total Revenue (TTM)
$40.36M
Gross Profit (TTM)
$27.68M
EBITDA (TTM)
-$322.10M
Year Range
$3.60 - $34.27
ROA (TTM)
-136.23%
ROE (TTM)
212.41%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Scilex Holding Company

Often compared with SCLX:
SCLX vs. VOO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Scilex Holding Company, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Scilex Holding Company (SCLX) has returned -45.41% so far this year and -23.43% over the past 12 months.


Scilex Holding Company

1D
5.21%
1M
-18.88%
YTD
-45.41%
6M
-66.16%
1Y
-23.43%
3Y*
-71.48%
5Y*
-54.62%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 5, 2021, SCLX's average daily return is -0.08%, while the average monthly return is -1.49%.

Historically, 52% of months were positive and 48% were negative. The best month was Jul 2025 with a return of +127.8%, while the worst month was Nov 2022 at -56.8%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 7 months.

On a daily basis, SCLX closed higher 41% of trading days. The best single day was Apr 5, 2023 with a return of +56.6%, while the worst single day was Mar 1, 2024 at -41.2%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-30.16%-3.64%-18.88%-45.41%
2025-3.40%-42.70%5.30%-45.50%8.02%15.04%127.84%32.34%10.81%-16.16%23.39%-40.08%-18.25%
2024-19.61%38.41%-29.96%-46.34%26.58%78.70%-17.62%-27.67%-19.60%3.86%-32.94%-33.79%-79.10%
202397.74%9.63%-5.20%-11.71%-17.82%-6.39%-1.80%-47.53%-51.22%33.57%-33.16%63.20%-48.87%
20220.50%0.40%0.49%0.00%0.29%0.10%0.78%0.39%-0.10%0.87%-56.80%-11.35%-60.26%
20210.30%0.61%-0.40%0.20%0.40%0.20%0.20%0.21%0.30%-0.11%1.93%

Benchmark Metrics

Scilex Holding Company has an annualized alpha of -23.36%, beta of 0.52, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since March 08, 2021.

  • This stock participated in 235.72% of S&P 500 Index downside but only 0.29% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.52 may look defensive, but with R² of 0.01 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-23.36%
Beta
0.52
0.01
Upside Capture
0.29%
Downside Capture
235.72%

Return for Risk

Risk / Return Rank

SCLX ranks 37 for risk / return — below 37% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


SCLX Risk / Return Rank: 3737
Overall Rank
SCLX Sharpe Ratio Rank: 3232
Sharpe Ratio Rank
SCLX Sortino Ratio Rank: 4545
Sortino Ratio Rank
SCLX Omega Ratio Rank: 4242
Omega Ratio Rank
SCLX Calmar Ratio Rank: 3232
Calmar Ratio Rank
SCLX Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Scilex Holding Company (SCLX) and compare them to a chosen benchmark (S&P 500 Index).


SCLXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.19

0.90

-1.08

Sortino ratio

Return per unit of downside risk

0.63

1.39

-0.76

Omega ratio

Gain probability vs. loss probability

1.07

1.21

-0.14

Calmar ratio

Return relative to maximum drawdown

-0.28

1.40

-1.68

Martin ratio

Return relative to average drawdown

-0.45

6.61

-7.06

Explore SCLX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Scilex Holding Company doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Scilex Holding Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Scilex Holding Company was 99.23%, occurring on Apr 22, 2025. The portfolio has not yet recovered.

The current Scilex Holding Company drawdown is 98.71%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.23%Apr 13, 2023508Apr 22, 2025
-72.67%Nov 9, 202233Dec 27, 202215Jan 19, 202348
-42.23%Jan 23, 20232Jan 24, 202350Apr 5, 202352
-16.08%Oct 27, 20227Nov 4, 20222Nov 8, 20229
-8.13%Apr 11, 20231Apr 11, 20231Apr 12, 20232

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Scilex Holding Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Scilex Holding Company is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SCLX relative to other companies in the Drug Manufacturers - General industry. Currently, SCLX has a P/S ratio of 1.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items